Dergiler / Haseki Tıp Bülteni / 2022 / Cilt: 60 - Sayı: 1

A Large-scale Pilot Breast Cancer Screening Program: Findings and Recommendations for National Screening Programs

Sayfa
1–6
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: For a breast screening program to reach the entirety of the target population, a comprehensive approach to every step of the process (screening, diagnosis, treatment) needs to be considered together.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Breast cancer is the most prevalent cancer diagnosed in women.
📊
Temel Bulgular & Veri:Screening programs to diagnose breast anomalies increase the likelihood of early diagnosis and survival.
💡
Sonuç & Katkı:Conclusion: For a breast screening program to reach the entirety of the target population, a comprehensive approach to every step of the process (screening, diagnosis, treatment) needs to be considered together.
🔬Tür:Araştırma Makalesi
📍Kapsam:2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: Breast cancer is the most prevalent cancer diagnosed in women. Screening programs to diagnose breast anomalies increase the likelihood of early diagnosis and survival. This study describes the most extensive breast cancer screening program in Istanbul/Turkey between 2018 and 2019 and offers recommendations for nationwide programs. Methods: We collected data from the Istanbul Health Directorate’s cancer surveillance database from May 2018 to December 2019. We analyzed data on patients referred for further investigation due to suspicion of possible tumors in their screening radiography. The database included socio-demographic information and further examination details (tests, outcomes, and planned treatment). Results: The mean age of the 3,577 women who were invited for further examination was 52.3 [standard deviation (SD): 7.5]. The age group with the highest percentage of further investigation invitations was between 50 and 54. The mean time between the results of screening mammography was 16.2 days (SD: 15.3). 5.1% of the women referred were diagnosed with some sort of cancer. Women who went to the place of scheduled appointments, instead of getting an appointment in another place of their choosing, were diagnosed and treated earlier. Conclusion: For a breast screening program to reach the entirety of the target population, a comprehensive approach to every step of the process (screening, diagnosis, treatment) needs to be considered together.

🔖

Bu Makaleye Atıf Yap

ŞİMŞEK, E. E., GUNER, A. E., SÜRMELİ, A., KURAL, K., Maral, L., TURAN, G. (2022). A Large-scale Pilot Breast Cancer Screening Program: Findings and Recommendations for National Screening Programs. Haseki Tıp Bülteni, Cilt: 60 - Sayı: 1, 1–6. https://ajindex.com/articles/534945

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. IARC, age-standardized (World) Incidence Rates, Breast, All ages, International Agency for Research on Cancer, WHO. 2018. Available from:
  2. T.C. Sağlık Bakanlığı, Türkiye kanser İstatistikleri 2016, Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. 2019. Available from: https://hsgm.saglik.gov.tr/depo/birimler/ kanser-db/istatistik/Trkiye_Kanser_statistikleri_2016.pdf 3. Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020
  3. American Cancer Society. Breast cancer facts & figures 2017- 2018. Available from: https://www.cancer.org/content/dam/ cancer-org/research/cancer-facts-and-statistics/breast-cancerfacts- and-figures/breast-cancer-facts-and figures-2017-2018. pdf
  4. Selda S. Meme Kanseri Taraması: Son Yenilikler Neler ? TSK Koruyucu Hekim Bülteni 2011;10:193-200
  5. Bjurstam NG, Björneld LM, Duffy SW. Updated results of the Gothenburg Trial of Mammographic Screening. Cancer 2016;122:1832-5
  6. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: A systematic review for the American College of Physicians. Ann Intern Med 2007;146:516-26
  7. Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW. Effect of mammographic screening from Age 40 years on breast cancer mortality in the UK Age trial at 17 years follow-up: a randomized controlled trial. Lancet Oncol 2015;16:1123-32
  8. American Cancer Society, Breast Cancer Early Detection and Diagnosis, Recommendations for the Early Detection of Breast Cancer, 2016. Available from: https://www.cancer. org/content/dam/CRC/PDF/Public/8579.00.pdf 10. Türkiye İstatistik Kurumu, Adrese Dayalı Nüfus Kayıt Sistemi Sonuçları, 2019 https://data.tuik.gov.tr/Bulten/Index?p=Adrese- Dayali-Nufus-Kayit-Sistemi-Sonuclari-2019-33705 11. Duffy SW, Vulkan D, Cuckle H, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Lancet Oncol 2020;21:1165-72
  9. Stanley E, Lewis MC, Irshad A, et al. Effectiveness of a mobile mammography program. AJR Am J Roentgenol 2017;209:1426-9
  10. Siu AL; U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med 2016;164:279-96.